Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
Medtronic
Teva
Farmers Insurance
Healthtrust

Generated: March 18, 2019

DrugPatentWatch Database Preview

Dalbavancin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dalbavancin hydrochloride and what is the scope of dalbavancin hydrochloride freedom to operate?

Dalbavancin hydrochloride is the generic ingredient in one branded drug marketed by Allergan Sales Llc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Dalbavancin hydrochloride has fifty-four patent family members in seventeen countries.

One supplier is listed for this compound.

Summary for dalbavancin hydrochloride
International Patents:54
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 1
Clinical Trials: 18
DailyMed Link:dalbavancin hydrochloride at DailyMed
Pharmacology for dalbavancin hydrochloride
Synonyms for dalbavancin hydrochloride
247175-55-9
808UI9MS5K
A-A-1
B0U42518WL
BI 397
BI-397
BI397
CHEBI:82721
CHEMBL3301650
CHEMBL3301669
CS-3579
Dalbavancin
Dalbavancin [USAN:INN:BAN]
dalbavancin B0
Dalvance
HY-17586
KGPGQDLTDHGEGT-SZUNQUCBSA-N
MDL 63,397
MDL 64,397
MDL-64397
UNII-808UI9MS5K
UNII-808UI9MS5K component KGPGQDLTDHGEGT-SZUNQUCBSA-N
UNII-B0U42518WL
VER 001
VER001
VERO001
Xydalba

US Patents and Regulatory Information for dalbavancin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;INTRAVENOUS 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;INTRAVENOUS 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;INTRAVENOUS 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;INTRAVENOUS 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;INTRAVENOUS 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Queensland Health
Boehringer Ingelheim
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.